Literature DB >> 24981998

More than memory impairment in voltage-gated potassium channel complex encephalopathy.

B M Bettcher1, J M Gelfand, S R Irani, J Neuhaus, S Forner, C P Hess, M D Geschwind.   

Abstract

BACKGROUND AND
PURPOSE: Autoimmune encephalopathies (AEs) are a heterogeneous group of neurological disorders that affect cognition. Although memory difficulties are commonly endorsed, few reports of AEs inclusively assess all cognitive domains in detail. Our aim was to perform an unbiased cognitive evaluation of AE patients with voltage-gated potassium channel complex antibodies (VGKCC -Abs) in order to delineate cognitive strengths and weaknesses.
METHODS: Serial VGKCC -Ab AE subjects (n = 12) were assessed with a comprehensive evaluation of memory, executive functions, visuospatial skills and language. Clinical magnetic resonance imaging (MRI) (n = 10/12) was evaluated. Five subjects had serial cognitive testing available, permitting descriptive analysis of change.
RESULTS: Subjects demonstrated mild to moderate impairment in memory (mean Z = -1.9) and executive functions (mean Z = -1.5), with variable impairments in language and sparing of visuospatial skills. MRI findings showed T2 hyperintensities in medial temporal lobe (10/10) and basal ganglia (2/10). Serial cognitive examination revealed heterogeneity in cognitive function; whereas most patients improved in one or more domains, residual impairments were observed in some patients.
CONCLUSIONS: This study augments previous neuropsychological analyses in VGKCC -Ab AE by identifying not only memory and executive function deficits but also language impairments, with preservation of visuospatial functioning. The study further highlights the importance of domain-specific testing to parse out the complex cognitive phenotypes of VGKCC -Ab AE.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  LGI1; autoimmune; cognitive

Mesh:

Substances:

Year:  2014        PMID: 24981998      PMCID: PMC4162838          DOI: 10.1111/ene.12482

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  19 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.

Authors:  George K Tofaris; Sarosh R Irani; Binith J Cheeran; Ian W S Baker; Zameel M Cader; Angela Vincent
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

3.  Unusual amnesia in a patient with VGKC-Ab limbic encephalitis: a case study.

Authors:  Luke D Kartsounis; Rajith de Silva
Journal:  Cortex       Date:  2010-02-17       Impact factor: 4.027

4.  Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.

Authors:  Michael P Malter; Christoph Helmstaedter; Horst Urbach; Angela Vincent; Christian G Bien
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

5.  Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report.

Authors:  Vittoria Cianci; Angelo Labate; Pierluigi Lanza; Angela Vincent; Antonio Gambardella; Damiano Branca; Luciano Arcudi; Umberto Aguglia
Journal:  Seizure       Date:  2010-07-02       Impact factor: 3.184

Review 6.  Autoimmune encephalitis -- new awareness, challenging questions.

Authors:  Sarosh R Irani; Angela Vincent
Journal:  Discov Med       Date:  2011-05       Impact factor: 2.970

7.  Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis.

Authors:  C Frisch; M P Malter; C E Elger; C Helmstaedter
Journal:  Eur J Neurol       Date:  2013-05-17       Impact factor: 6.089

8.  Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia.

Authors:  Katherine L Possin; Victor R Laluz; Oscar Z Alcantar; Bruce L Miller; Joel H Kramer
Journal:  Neuropsychologia       Date:  2010-10-26       Impact factor: 3.139

9.  Morvan syndrome: clinical and serological observations in 29 cases.

Authors:  Sarosh R Irani; Philippa Pettingill; Kleopas A Kleopa; Natasa Schiza; Patrick Waters; Claudio Mazia; Luigi Zuliani; Osamu Watanabe; Bethan Lang; Camilla Buckley; Angela Vincent
Journal:  Ann Neurol       Date:  2012-04-04       Impact factor: 10.422

10.  Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.

Authors:  Masahito Takagi; Yasushi Ishigaki; Kenji Uno; Shojiro Sawada; Junta Imai; Keizo Kaneko; Yutaka Hasegawa; Tetsuya Yamada; Ai Tokita; Kazumi Iseki; Shigenori Kanno; Yoshiyuki Nishio; Hideki Katagiri; Etsuro Mori
Journal:  BMC Neurol       Date:  2013-07-09       Impact factor: 2.474

View more
  7 in total

1.  Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.

Authors:  Georges Naasan; Sarosh R Irani; Brianne M Bettcher; Michael D Geschwind; Jeffrey M Gelfand
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

2.  Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Authors:  Helena Ariño; Thais Armangué; Mar Petit-Pedrol; Lidia Sabater; Eugenia Martinez-Hernandez; Makoto Hara; Eric Lancaster; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

3.  Human hippocampal CA3 damage disrupts both recent and remote episodic memories.

Authors:  Thomas D Miller; Trevor T-J Chong; Anne M Aimola Davies; Michael R Johnson; Sarosh R Irani; Masud Husain; Tammy Wc Ng; Saiju Jacob; Paul Maddison; Christopher Kennard; Penny A Gowland; Clive R Rosenthal
Journal:  Elife       Date:  2020-01-24       Impact factor: 8.140

4.  Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis.

Authors:  Thomas D Miller; Trevor T-J Chong; Anne M Aimola Davies; Tammy W C Ng; Michael R Johnson; Sarosh R Irani; Angela Vincent; Masud Husain; Saiju Jacob; Paul Maddison; Christopher Kennard; Penny A Gowland; Clive R Rosenthal
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

5.  The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Authors:  Julia Thompson; Mian Bi; Andrew G Murchison; Mateusz Makuch; Christian G Bien; Kon Chu; Pue Farooque; Jeffrey M Gelfand; Michael D Geschwind; Lawrence J Hirsch; Ernest Somerville; Bethan Lang; Angela Vincent; Maria I Leite; Patrick Waters; Sarosh R Irani
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

6.  Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis.

Authors:  Nuria Sola-Valls; Helena Ariño; Domingo Escudero; Elisabeth Solana; Albert Lladó; Raquel Sánchez-Valle; Yolanda Blanco; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-17

Review 7.  Limbic Encephalitis: Potential Impact of Adaptive Autoimmune Inflammation on Neuronal Circuits of the Amygdala.

Authors:  Nico Melzer; Thomas Budde; Oliver Stork; Sven G Meuth
Journal:  Front Neurol       Date:  2015-08-03       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.